Epizyme Story

EPZM -- USA Stock  

USD 12.23  0.15  1.24%

Macroaxis does not monitor all media channels or aggregates social signals for Epizyme. But even though we do not provide professional-grade financial sentiment analysis on Epizyme, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Epizyme. Additionally see Epizyme Hype Analysis, Epizyme Correlation and Epizyme Performance.
Acquisition by Michael Giordano of 25000 shares of Epizyme subject to Rule 16b-3
Filed transaction by Epizyme Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Epizyme Inc insider trading alert for grant of stock option (right to buy) by Michael Giordano, the corporate stakeholder, on March 12, 2018. This event was filed by Epizyme Inc with SEC on 2018-03-12. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This media report from MacroaxisInsider distributed on March 12, 2018 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 3.25% . The overall trading delta when the story was published against the current closing price is 33.06% .

Similar stores for Epizyme

few days ago at standardrecorder.com 
Alexion Pharmaceuticals Inc. and Epizyme Inc. Comparison side by side - Standard Recorder
news
Alexion Pharmaceuticals Inc. and Epizyme Inc. Comparison side by side Standard RecorderAs Biotechnology companies, Alexion Pharmaceuticals Inc. and Epizyme Inc. are our subject to compare. And more ...
over a week ago at www.thecoinguild.com 
Stock Update Investors Taking a Second Look at Epizyme, Inc. After Recent Market Moves - The Coin Guild
news
Stock Update Investors Taking a Second Look at Epizyme, Inc. After Recent Market Moves The Coin GuildReviewing Epizyme Inc. s and BioMarin Pharmaceutical Inc. s results The FinHeadLinesEpizyme, Inc. Rises to 12.70 on Mar, 12 The EN BulletinEpizyme, Inc. Increased to 12.70 on Mar, 12 Z TribuneSina Gets BidaskScore Lower Rating Hudson Bay Capital Management LP Boosted Epizyme Stake By 404,838 The Yomi BlogView full coverage on Google News
over a week ago at nysenasdaqnews.com 
Sky-High Price Targets Justified Epizyme, Inc., - Nyse Nasdaq News
nasdaq News
Sky-High Price Targets Justified Epizyme, Inc., Nyse Nasdaq NewsEye-Catching Hot Stocks Epizyme, Inc., StocksNewsProAnalyst EPS Estimates Coverage Epizyme, Inc. Analyst JournalView full coverage on Google News
over two weeks ago at whatsonthorold.com 
Time to Buy Epizyme, Inc. After Todays Huge Decline Thorold News - Thorold News
news
Time to Buy Epizyme, Inc. After Todays Huge Decline Thorold News Thorold NewsInvestors sentiment decreased to 1.28 in 2018 Q3. Its down 0.12, from 1.4 in 2018Q2. It dived, as 12 investors sold Epizyme, Inc. shares while 24 reduced.
over three weeks ago at hinewulm.com 
Epizyme Inc. s Financial Results Comparing With China Biologic Products Holdings Inc. - The Hi New Ulm
news
Epizyme Inc. s Financial Results Comparing With China Biologic Products Holdings Inc. The Hi New UlmThis is therefore a contrasting of the dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation in Epizyme Inc.
over three weeks ago at www.fairfieldcurrent.com 
Epizyme Lifted to Buy at BidaskClub - Fairfield Current
news
Epizyme Lifted to Buy at BidaskClub Fairfield CurrentEpizyme, Inc. Cant Be More Risky. Trades Sigfnicicantly Lower Thorold News Thorold NewsEpizyme, Inc. Analysts See -0.50 EPS Jabil Inc. Had 1 Analysts Last Week Port CourierEpizyme Stock Price Down 5.5 PressOracleII-VI Reaches 40.71 After 3.00 percent Up Move Epizyme Has 1.28 Sentiment Standard RecorderView full coverage on Google News
over a month ago at stocknewsoracle.com 
Stock Radar Watching the Numbers for Epizyme, Inc. - Stock News Oracle
News Oracle News
Stock Radar Watching the Numbers for Epizyme, Inc. Stock News OracleSharp investors are usually looking for true bargains in the stock market. Finding these stocks can help give the stock portfolio a boost. Shares of Epizyme, Inc.
over a month ago at www.fairfieldcurrent.com 
Quantamental Technologies LLC Buys New Holdings in Epizyme Inc - Fairfield Current
news
Quantamental Technologies LLC Buys New Holdings in Epizyme Inc Fairfield CurrentQuantamental Technologies LLC bought a new position in Epizyme Inc in the fourth quarter, according to the company in its most recent ...
over a month ago at hinewulm.com 
As Epizyme Market Valuation Declined, Foresite Capital Management Ii Has Cut Its Holding by 358,510 Alexandria...
news
As Epizyme Market Valuation Declined, Foresite Capital Management Ii Has Cut Its Holding by 358,510 Alexandria Capital Lowered Its Bristol Myers Squibb Co Com Position by 448,960 as Stock Price Declined The Hi New UlmForesite Capital Management Ii Llc decreased its stake in Epizyme Inc. by 2.44 percent based on its latest 2018Q3 regulatory filing with the SEC. Foresite ...
over a month ago at endigest.com 
Kinder Morgan Del Shareholder Dimensional Fund Advisors LP Trimmed Its Holding by 5.19 Million as Stock Value ...
news
Kinder Morgan Del Shareholder Dimensional Fund Advisors LP Trimmed Its Holding by 5.19 Million as Stock Value Declined As Epizyme Stock Value Declined, Holder Foresite Capital Management Ii Cut Its Holding EN DigestDimensional Fund Advisors Lp decreased its stake in Kinder Morgan Inc Del by 1.97 percent based on its latest 2018Q3 regulatory filing with the SEC.
over a month ago at MacroaxisInsider 
Acquisition by Joseph Beaulieu of 24523 shares of Epizyme subject to Rule 16b-3
Macroaxis News
Filed transaction by Epizyme Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
over three months ago at nasdaqclick.com 
Analysts Stock Ratings Trend Epizyme, Inc. - Nasdaq Click
nasdaq News
Analysts Stock Ratings Trend Epizyme, Inc. Nasdaq ClickEpizyme, Inc. s Stock Price Update Epizyme, Inc. stock price ended its day with loss -9.05 percent and finalized at the price of 6.73, its 52 week- peak ...
over three months ago at nasdaqclick.com 
Most Recent Analysts Ratings Report Epizyme, Inc.
nasdaq News
Nasdaq Click Full coverage

Operating Margin

Operating Margin Comparative Analysis

  Operating Margin 
      Epizyme Comparables 
Epizyme is currently under evaluation in operating margin category among related companies. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Additionally see Epizyme Hype Analysis, Epizyme Correlation and Epizyme Performance. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.
Search macroaxis.com